×
Entrez Id: 7037
Gene Symbol: TFRC
TFRC
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
High Fat Diet Induces Liver Steatosis and Early Dysregulation of Iron Metabolism in Rats.
23805238 2013
×
Entrez Id: 2936
Gene Symbol: GSR
GSR
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Comparative effect of pioglitazone, quercetin and hydroxy citric acid on the status of lipid peroxidation and antioxidants in experimental non-alcoholic steatohepatitis.
24622831 2014
×
Entrez Id: 3479
Gene Symbol: IGF1
IGF1
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
SusceptibilityMutation
RGD
Prenatal ethanol exposure programs an increased susceptibility of non-alcoholic fatty liver disease in female adult offspring rats.
24275070 2014
×
Entrez Id: 9927
Gene Symbol: MFN2
MFN2
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Effects of salvianolic acid B on liver mitochondria of rats with nonalcoholic steatohepatitis.
26401075 2015
×
Entrez Id: 57817
Gene Symbol: HAMP
HAMP
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Differences in hepatic expression of iron, inflammation and stress-related genes in patients with nonalcoholic steatohepatitis.
28051796 2017
×
Entrez Id: 7124
Gene Symbol: TNF
TNF
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Innate immune reactivity of the liver in rats fed a choline-deficient L-amino-acid-defined diet.
19034968 2008
×
Entrez Id: 51548
Gene Symbol: SIRT6
SIRT6
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Activation of peroxisome proliferator-activated receptor gamma by rosiglitazone increases sirt6 expression and ameliorates hepatic steatosis in rats.
21373642 2011
×
Entrez Id: 3030
Gene Symbol: HADHA
HADHA
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Proteomic analysis of liver mitochondria from rats with nonalcoholic steatohepatitis.
24782632 2014
×
Entrez Id: 3416
Gene Symbol: IDE
IDE
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Berberine Reduces Neurotoxicity Related to Nonalcoholic Steatohepatitis in Rats.
26576191 2015
×
Entrez Id: 3643
Gene Symbol: INSR
INSR
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
[Effects of Lactobacillus paracasei N1115 combined with fructooligosaccharides on non-alcoholic fatty liver disease induced by high-fat diet in mice].
29325294 2017
×
Entrez Id: 23409
Gene Symbol: SIRT4
SIRT4
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Calorie restriction on insulin resistance and expression of SIRT1 and SIRT4 in rats.
20651844 2010
×
Entrez Id: 4023
Gene Symbol: LPL
LPL
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Thiazolidinedione induces a therapeutic effect on hepatosteatosis by regulating stearoyl-CoA desaturase-1, lipase activity, leptin and resistin.
30214514 2018
×
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Kupffer cell depletion protects against the steatosis, but not the liver damage, induced by marginal-copper, high-fructose diet in male rats.
25813056 2015
PPARGC1A
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Activation of peroxisome proliferator-activated receptor gamma by rosiglitazone increases sirt6 expression and ameliorates hepatic steatosis in rats.
21373642 2011
×
Entrez Id: 6352
Gene Symbol: CCL5
CCL5
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress.
27639593 2017
×
Entrez Id: 5599
Gene Symbol: MAPK8
MAPK8
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression.
24404139 2014
×
Entrez Id: 7099
Gene Symbol: TLR4
TLR4
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis.
23301938 2013
×
Entrez Id: 84649
Gene Symbol: DGAT2
DGAT2
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Clostridium butyricum MIYAIRI 588 improves high-fat diet-induced non-alcoholic fatty liver disease in rats.
24166662 2013
×
Entrez Id: 8714
Gene Symbol: ABCC3
ABCC3
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Molecular mechanism of altered ezetimibe disposition in nonalcoholic steatohepatitis.
22112382 2012
×
Entrez Id: 1571
Gene Symbol: CYP2E1
CYP2E1
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Pioglitazone, quercetin and hydroxy citric acid effect on cytochrome P450 2E1 (CYP2E1) enzyme levels in experimentally induced non alcoholic steatohepatitis (NASH).
25317811 2014
×
Entrez Id: 4023
Gene Symbol: LPL
LPL
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
[Preventive and therapeutic effects of compound ginkgo extract in rats with nonalcoholic steatohepatitis induced by high-fat, high-fructose diet].
27978932 2016
×
Entrez Id: 6774
Gene Symbol: STAT3
STAT3
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
[Effects of puerarin on expressions of leptin receptor mRNA, phosphorylated Janus kinase 2/phosphorylated signal transducers and activators of transcription 3 proteins in the liver of rats with non-alcoholic fatty liver].
18782535 2008
×
Entrez Id: 7099
Gene Symbol: TLR4
TLR4
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
[Effect of electro-acupuncture on hepatic Toll-like receptor 4 and nuclear factor κB expressions in rats with non-alcoholic fatty liver disease].
25413054 2014
×
Entrez Id: 3480
Gene Symbol: IGF1R
IGF1R
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
SusceptibilityMutation
RGD
Prenatal ethanol exposure programs an increased susceptibility of non-alcoholic fatty liver disease in female adult offspring rats.
24275070 2014
×
Entrez Id: 5445
Gene Symbol: PON2
PON2
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Paraoxonase activity and expression is modulated by therapeutics in experimental rat nonalcoholic Fatty liver disease.
22536512 2012